These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31533883)

  • 1. Metformin and tuberculosis risk in elderly patients with diabetes mellitus.
    Park S; Yang BR; Song HJ; Jang SH; Kang DY; Park BJ
    Int J Tuberc Lung Dis; 2019 Aug; 23(8):924-930. PubMed ID: 31533883
    [No Abstract]   [Full Text] [Related]  

  • 2. The cumulative dose-dependent effects of metformin on the development of tuberculosis in patients newly diagnosed with type 2 diabetes mellitus.
    Heo E; Kim E; Jang EJ; Lee CH
    BMC Pulm Med; 2021 Sep; 21(1):303. PubMed ID: 34563159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Risk of TB in Patients With Type 2 Diabetes Initiating Metformin vs Sulfonylurea Treatment.
    Pan SW; Yen YF; Kou YR; Chuang PH; Su VY; Feng JY; Chan YJ; Su WJ
    Chest; 2018 Jun; 153(6):1347-1357. PubMed ID: 29253553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of metformin use among tuberculosis close contacts with diabetes mellitus in a nationwide cohort study.
    Lee MC; Lee CH; Lee MR; Wang JY; Chen SM
    BMC Infect Dis; 2019 Nov; 19(1):936. PubMed ID: 31694558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin is associated with a lower risk of active tuberculosis in patients with type 2 diabetes.
    Lin SY; Tu HP; Lu PL; Chen TC; Wang WH; Chong IW; Chen YH
    Respirology; 2018 Nov; 23(11):1063-1073. PubMed ID: 29943489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus.
    Tseng CH
    Diabetes Metab Res Rev; 2015 Sep; 31(6):619-26. PubMed ID: 25820555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased risk of affective disorders in type 2 diabetes is minimized by sulfonylurea and metformin combination: a population-based cohort study.
    Wahlqvist ML; Lee MS; Chuang SY; Hsu CC; Tsai HN; Yu SH; Chang HY
    BMC Med; 2012 Nov; 10():150. PubMed ID: 23194378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression to insulin therapy among patients with type 2 diabetes treated with sitagliptin or sulphonylurea plus metformin dual therapy.
    Inzucchi SE; Tunceli K; Qiu Y; Rajpathak S; Brodovicz KG; Engel SS; Mavros P; Radican L; Brudi P; Li Z; Fan CP; Hanna B; Tang J; Blonde L
    Diabetes Obes Metab; 2015 Oct; 17(10):956-64. PubMed ID: 25962401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality Associated with Metformin Versus Sulfonylurea Initiation: A Cohort Study of Veterans with Diabetes and Chronic Kidney Disease.
    Marcum ZA; Forsberg CW; Moore KP; de Boer IH; Smith NL; Boyko EJ; Floyd JS
    J Gen Intern Med; 2018 Feb; 33(2):155-165. PubMed ID: 29181788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin and endometrial cancer risk in Chinese women with type 2 diabetes mellitus in Taiwan.
    Tseng CH
    Gynecol Oncol; 2015 Jul; 138(1):147-53. PubMed ID: 25913129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are sulfonylurea and insulin therapies associated with a larger risk of cancer than metformin therapy? A retrospective database analysis.
    Kowall B; Rathmann W; Kostev K
    Diabetes Care; 2015 Jan; 38(1):59-65. PubMed ID: 25336750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin use is associated with a low risk of tuberculosis among newly diagnosed diabetes mellitus patients with normal renal function: A nationwide cohort study with validated diagnostic criteria.
    Lee MC; Chiang CY; Lee CH; Ho CM; Chang CH; Wang JY; Chen SM
    PLoS One; 2018; 13(10):e0205807. PubMed ID: 30335800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Important differences in the durability of glycaemic response among second-line treatment options when added to metformin in type 2 diabetes: a retrospective cohort study.
    Mamza J; Mehta R; Donnelly R; Idris I
    Ann Med; 2016; 48(4):224-34. PubMed ID: 26982210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfonylureas as Initial Treatment for Type 2 Diabetes and the Risk of Severe Hypoglycemia.
    Yu O; Azoulay L; Yin H; Filion KB; Suissa S
    Am J Med; 2018 Mar; 131(3):317.e11-317.e22. PubMed ID: 29032229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin.
    Hsu CC; Wahlqvist ML; Lee MS; Tsai HN
    J Alzheimers Dis; 2011; 24(3):485-93. PubMed ID: 21297276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects on Clinical Outcomes of Adding Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas to Metformin Therapy in Patients With Type 2 Diabetes Mellitus.
    Ou SM; Shih CJ; Chao PW; Chu H; Kuo SC; Lee YJ; Wang SJ; Yang CY; Lin CC; Chen TJ; Tarng DC; Li SY; Chen YT
    Ann Intern Med; 2015 Nov; 163(9):663-72. PubMed ID: 26457538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy with sulfonylureas and metformin and the prevention of death in type 2 diabetes: a nested case-control study.
    Azoulay L; Schneider-Lindner V; Dell'aniello S; Schiffrin A; Suissa S
    Pharmacoepidemiol Drug Saf; 2010 Apr; 19(4):335-42. PubMed ID: 20052677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between metformin use and mortality in tuberculosis patients with diabetes: a nationwide cohort study.
    Chung E; Jeong D; Mok J; Jeon D; Kang HY; Kim H; Kim H; Choi H; Kang YA
    Korean J Intern Med; 2024 Mar; 39(2):306-317. PubMed ID: 38317270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin Is Associated with a Lower Incidence of Benign Brain Tumors: A Retrospective Cohort Study in Patients with Type 2 Diabetes Mellitus.
    Tseng CH
    Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680039
    [No Abstract]   [Full Text] [Related]  

  • 20. Association Between Metformin Initiation and Incident Dementia Among African American and White Veterans Health Administration Patients.
    Scherrer JF; Morley JE; Salas J; Floyd JS; Farr SA; Dublin S
    Ann Fam Med; 2019 Jul; 17(4):352-362. PubMed ID: 31285213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.